Free Trial
Your Rate Never Goes Up! Save $100 a Year on MarketBeat All Access
Upgrade Now
Claim MarketBeat All Access Sale Promotion
Brian Abrahams

Brian Abrahams Analyst Performance

Analyst at Royal Bank Of Canada

Brian Abrahams is a stock analyst at Royal Bank Of Canada focused in the healthcare sector, covering 41 publicly traded companies. Over the past year, Brian Abrahams has issued 120 stock ratings, including buy, hold, and sell recommendations. While full access to Brian Abrahams' proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Brian Abrahams' coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
333 Last 11 Years
Buy Recommendations
63.75% 211 Buy Ratings
Companies Covered
41 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy63.7%211 ratings
Hold36.0%119 ratings
Sell0.3%1 ratings

Out of 331 total stock ratings issued by Brian Abrahams at Royal Bank Of Canada, the majority (63.7%) have been Buy recommendations, followed by 36.0% Hold and 0.3% Sell.

Exchange Coverage

ExchangePercentageCount
NASDAQ
95.1% of companies on NASDAQ
39 companies
NYSE
4.9% of companies on NYSE
2 companies

Brian Abrahams, an analyst at Royal Bank Of Canada, currently covers 41 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Healthcare
40 companies
97.6%
Miscellaneous
1 company
2.4%

Brian Abrahams of Royal Bank Of Canada specializes in stock coverage within the Healthcare sector, with additional focus on companies.

Coverage Industries

IndustryPercentage
BIOTECHNOLOGY
28 companies
68.3%
PHARMACEUTICALS
12 companies
29.3%
Miscellaneous
1 company
2.4%

About Brian Abrahams

Dr. Brian Abrahams joined RBC Capital Markets in July 2017 as a senior analyst covering the biotechnology sector. He has 15 years of experience following large, mid, and small cap biotech companies, and prior to RBC spent time in biotechnology equity research at Jefferies, Wells Fargo, and CIBC World Markets / Oppenheimer & Co. He is a licensed non-practicing physician and holds a medical degree from the Albert Einstein College of Medicine. He did his undergraduate studies at Yale University, where he graduated magna cum laude with a Bachelor of Science degree in Molecular Biophysics & Biochemistry.
Follow on LinkedIn

Brian Abrahams' Ratings History at Royal Bank Of Canada

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
0 Results
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Aardvark Therapeutics, Inc. stock logo
AARD
Aardvark Therapeutics
10/23/2026Set Price Target$1.69$2.50
Definium Therapeutics, Inc. stock logo
DFTX
Definium Therapeutics
10/19/2026Reiterated Rating$32.83Outperform
Nurix Therapeutics, Inc. stock logo
NRIX
Nurix Therapeutics
10/13/2026Lower Price Target$22.16$35.00Outperform
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
10/8/2026Boost Price Target$507.16$576.00Outperform
Incyte Corporation stock logo
INCY
Incyte
10/8/2026Boost Price Target$112.27$114.00Sector Perform
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
10/8/2026Lower Price Target$17.40$17.00Sector Perform
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
10/8/2026Boost Price Target$730.07$810.00Sector Perform
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
10/8/2026Boost Price Target$145.57$126.00Sector Perform
Biogen Inc. stock logo
BIIB
Biogen
10/8/2026Lower Price Target$219.48$256.00Outperform
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
10/8/2026Lower Price Target$19.46$36.00Outperform
PTC Therapeutics, Inc. stock logo
PTCT
PTC Therapeutics
10/7/2026Lower Price Target$63.70$75.00Sector Perform
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
9/29/2026Reiterated Rating$752.25$737.00Sector Perform
Aardvark Therapeutics, Inc. stock logo
AARD
Aardvark Therapeutics
9/24/2026Reiterated Rating$5.50$6.00Sector Perform
Lakefront Biotherapeutics American Depositary Shares stock logo
LKFT
Lakefront Biotherapeutics American Depositary Shares
9/23/2026Upgrade$30.19$45.00Outperform
Incyte Corporation stock logo
INCY
Incyte
9/22/2026Reiterated Rating$125.09$109.00Sector Perform
Xenon Pharmaceuticals Inc. stock logo
XENE
Xenon Pharmaceuticals
9/18/2026Lower Price Target$41.17$70.00Outperform
Definium Therapeutics, Inc. stock logo
DFTX
Definium Therapeutics
9/11/2026Reiterated Rating$38.60$66.00Outperform
BioCryst Pharmaceuticals, Inc. stock logo
BCRX
BioCryst Pharmaceuticals
9/10/2026Downgrade$8.81$11.00Sector Perform
Evommune, Inc. stock logo
EVMN
Evommune
9/9/2026Lower Price Target$11.25$21.00Outperform
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
9/8/2026Reiterated Rating$156.07$198.00Outperform
ATTO
Attovia Therapeutics
8/31/2026Initiated Coverage$20.70$45.00Outperform
ATTO
Attovia Therapeutics
8/30/2026Upgrade$21.40Moderate Buy
Biogen Inc. stock logo
BIIB
Biogen
8/25/2026Boost Price Target$218.12$260.00Outperform
Definium Therapeutics, Inc. stock logo
DFTX
Definium Therapeutics
8/13/2026Boost Price Target$44.46$66.00Outperform
Pharvaris N.V. stock logo
PHVS
Pharvaris
8/13/2026Boost Price Target$34.56$52.00Outperform
Lakefront Biotherapeutics American Depositary Shares stock logo
LKFT
Lakefront Biotherapeutics American Depositary Shares
8/11/2026Lower Price Target$27.96$26.00Sector Perform
Nurix Therapeutics, Inc. stock logo
NRIX
Nurix Therapeutics
8/10/2026Boost Price Target$25.57$36.00Outperform
Xenon Pharmaceuticals Inc. stock logo
XENE
Xenon Pharmaceuticals
8/7/2026Lower Price Target$63.64$81.00Outperform
Evommune, Inc. stock logo
EVMN
Evommune
8/7/2026Lower Price Target$14.20$29.00Outperform
BioCryst Pharmaceuticals, Inc. stock logo
BCRX
BioCryst Pharmaceuticals
8/6/2026Lower Price Target$9.42$13.00Outperform
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
8/5/2026Boost Price Target$28.32$37.00Outperform
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
8/5/2026Boost Price Target$130.70$123.00Sector Perform
Contineum Therapeutics, Inc. stock logo
CTNM
Contineum Therapeutics
7/31/2026Boost Price Target$15.27$23.00Outperform
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
7/31/2026Boost Price Target$763.17$737.00Sector Perform
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
7/31/2026Boost Price Target$166.77$198.00Outperform
Biogen Inc. stock logo
BIIB
Biogen
7/30/2026Lower Price Target$205.31$240.00Outperform
Incyte Corporation stock logo
INCY
Incyte
7/29/2026Boost Price Target$127.16$109.00Sector Perform
Kymera Therapeutics, Inc. stock logo
KYMR
Kymera Therapeutics
7/13/2026Downgrade$119.35$115.00Sector Perform
Neumora Therapeutics, Inc. stock logo
NMRA
Neumora Therapeutics
7/13/2026Lower Price Target$1.62$5.00Outperform
Nurix Therapeutics, Inc. stock logo
NRIX
Nurix Therapeutics
7/10/2026Boost Price Target$23.97$33.00Outperform
Why tech stocks are dead (Ad)

AI skeptics see dot-com era warning signs, and they have a point. But the real opportunity may not be in the big tech names pouring billions into data centers. Walmart's $24 million satellite network, AMR's Sabre system, and Capital One's 36,114 pricing tests all prove the same thing: compute has always been business's biggest moat, and it's about to get cheaper than ever. Porter Stansberry says one overlooked, government-protected sector is positioned to absorb this near-free compute boom and could become the next Magnificent 7.tc pixel

Watch Porter Stansberry's broadcast to see which sector could lead next
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
7/7/2026Boost Price Target$529.59$570.00Outperform
PTC Therapeutics, Inc. stock logo
PTCT
PTC Therapeutics
7/7/2026Boost Price Target$85.44$85.00Sector Perform
Incyte Corporation stock logo
INCY
Incyte
7/7/2026Boost Price Target$115.62$99.00Sector Perform
Biogen Inc. stock logo
BIIB
Biogen
7/7/2026Boost Price Target$208.46$242.00Outperform
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
7/7/2026Boost Price Target$25.77$36.00Outperform
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
7/7/2026Lower Price Target$668.88$696.00Sector Perform
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
7/7/2026Boost Price Target$178.11$195.00Outperform
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
7/7/2026Lower Price Target$134.71$120.00Sector Perform
BioCryst Pharmaceuticals, Inc. stock logo
BCRX
BioCryst Pharmaceuticals
7/7/2026Boost Price Target$10.19$14.00Outperform
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
6/8/2026Reiterated Rating$129.17Sector Perform
Apogee Therapeutics Inc. stock logo
APGE
Apogee Therapeutics
6/8/2026Boost Price Target$86.92$97.00Sector Perform
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
6/1/2026Reiterated Rating$134.43$122.00Overweight
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
6/1/2026Upgrade$131.10Moderate Buy
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
5/29/2026Boost Price Target$157.47$183.00Outperform
Biogen Inc. stock logo
BIIB
Biogen
5/27/2026Boost Price Target$193.08$227.00Outperform
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
5/18/2026Lower Price Target$623.32$707.00Sector Perform
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
5/8/2026Lower Price Target$130.55$122.00Sector Perform
PTC Therapeutics, Inc. stock logo
PTCT
PTC Therapeutics
5/8/2026Boost Price Target$79.08$82.00Sector Perform
Xenon Pharmaceuticals Inc. stock logo
XENE
Xenon Pharmaceuticals
5/8/2026Boost Price Target$55.89$82.00Outperform
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
5/6/2026Boost Price Target$144.90$180.00Outperform
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
5/5/2026Boost Price Target$429.85$543.00Outperform
Biogen Inc. stock logo
BIIB
Biogen
4/30/2026Boost Price Target$191.32$222.00Outperform
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
4/30/2026Lower Price Target$707.09$762.00Sector Perform
Biogen Inc. stock logo
BIIB
Biogen
4/29/2026Boost Price Target$191.58$222.00Outperform
Damora Therapeutics, Inc. Common Stock stock logo
DMRA
Damora Therapeutics, Inc. Common Stock
4/24/2026Initiated Coverage$25.42$40.00Outperform
Damora Therapeutics, Inc. Common Stock stock logo
DMRA
Damora Therapeutics, Inc. Common Stock
4/23/2026Upgrade$24.75Moderate Buy
Evommune, Inc. stock logo
EVMN
Evommune
4/10/2026Reiterated Rating$27.56$48.00Outperform
Pharvaris N.V. stock logo
PHVS
Pharvaris
4/6/2026Lower Price Target$28.56$51.00Outperform
Pharvaris N.V. stock logo
PHVS
Pharvaris
3/9/2026Initiated Coverage$26.63$52.00Outperform
Apogee Therapeutics Inc. stock logo
APGE
Apogee Therapeutics
3/2/2026Lower Price Target$70.92$82.00Sector Perform
Aardvark Therapeutics, Inc. stock logo
AARD
Aardvark Therapeutics
3/2/2026Downgrade$12.49$6.00Sector Perform
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
3/2/2026Boost Price Target$784.09$765.00Sector Perform
MoonLake Immunotherapeutics stock logo
MLTX
MoonLake Immunotherapeutics
3/2/2026Boost Price Target$17.69$13.00Sector Perform
Kymera Therapeutics, Inc. stock logo
KYMR
Kymera Therapeutics
2/26/2026Reiterated Rating$91.56$108.00Outperform
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
2/26/2026Lower Price Target$24.82$30.00Outperform
Lakefront Biotherapeutics American Depositary Shares stock logo
LKFT
Lakefront Biotherapeutics American Depositary Shares
2/24/2026Boost Price Target$34.36$33.00Sector Perform
PTC Therapeutics, Inc. stock logo
PTCT
PTC Therapeutics
2/20/2026Lower Price Target$69.90$82.00Sector Perform
MoonLake Immunotherapeutics stock logo
MLTX
MoonLake Immunotherapeutics
2/20/2026Boost Price Target$17.86$12.00Sector Perform
Prothena Corporation plc stock logo
PRTA
Prothena
2/20/2026Boost Price Target$8.83$12.00Sector Perform
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
2/13/2026Lower Price Target$496.69$541.00Outperform
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
2/12/2026Lower Price Target$126.01$177.00Outperform
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
2/11/2026Boost Price Target$156.39$118.00Sector Perform
Incyte Corporation stock logo
INCY
Incyte
2/11/2026Lower Price Target$98.59$92.00Sector Perform
Biogen Inc. stock logo
BIIB
Biogen
2/9/2026Boost Price Target$201.18$233.00Outperform
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
2/3/2026Lower Price Target$26.13$31.00Outperform
BioCryst Pharmaceuticals, Inc. stock logo
BCRX
BioCryst Pharmaceuticals
1/30/2026Lower Price Target$6.44$13.00Outperform
Nurix Therapeutics, Inc. stock logo
NRIX
Nurix Therapeutics
1/29/2026Boost Price Target$17.60$30.00Outperform
GH Research PLC stock logo
GHRS
GH Research
1/23/2026Boost Price Target$16.46$40.00Outperform
Definium Therapeutics, Inc. stock logo
DFTX
Definium Therapeutics
1/23/2026Boost Price Target$17.29$36.00Outperform
Apogee Therapeutics Inc. stock logo
APGE
Apogee Therapeutics
1/22/2026Downgrade$81.91$83.00Sector Perform
Financial legend: “This is bad, really bad...” (Ad)

Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each warning issued before the crisis hit. Now the founder of Weiss Ratings, the only conflict-free rating agency in America, says he is watching a $3 trillion problem that could trigger a chain reaction across markets and banks.tc pixel

See Martin Weiss's full warning before this risk spreads further
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
1/22/2026Upgrade$461.14$546.00Outperform
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
1/20/2026Boost Price Target$124.91$103.00Sector Perform
Biogen Inc. stock logo
BIIB
Biogen
1/13/2026Reiterated Rating$178.30Outperform
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
1/8/2026Lower Price Target$121.35$100.00Sector Perform
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
1/8/2026Boost Price Target$21.31$18.00Sector Perform
Apogee Therapeutics Inc. stock logo
APGE
Apogee Therapeutics
1/6/2026Reiterated Rating$78.59Outperform
Kymera Therapeutics, Inc. stock logo
KYMR
Kymera Therapeutics
12/16/2025Boost Price Target$85.68$103.00Outperform
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
12/8/2025Boost Price Target$159.46$180.00Outperform
PTC Therapeutics, Inc. stock logo
PTCT
PTC Therapeutics
12/1/2025Downgrade$85.99$91.00Sector Perform
Neumora Therapeutics, Inc. stock logo
NMRA
Neumora Therapeutics
12/1/2025Upgrade$2.26$7.00Outperform
Sionna Therapeutics, Inc. stock logo
SION
Sionna Therapeutics
12/1/2025Reiterated Rating$43.57$24.00Underperform
Contineum Therapeutics, Inc. stock logo
CTNM
Contineum Therapeutics
11/21/2025Lower Price Target$11.08$22.00Outperform
Cidara Therapeutics, Inc. stock logo
CDTX
Cidara Therapeutics
11/17/2025Downgrade$217.78Sector Perform
Aardvark Therapeutics, Inc. stock logo
AARD
Aardvark Therapeutics
11/14/2025Lower Price Target$10.86$18.00Outperform
Corbus Pharmaceuticals Holdings, Inc. stock logo
CRBP
Corbus Pharmaceuticals
11/13/2025Lower Price Target$11.09$53.00Outperform
Prothena Corporation plc stock logo
PRTA
Prothena
11/7/2025Boost Price Target$10.15$11.00Sector Perform
Definium Therapeutics, Inc. stock logo
DFTX
Definium Therapeutics
11/7/2025Lower Price Target$11.26$20.00Outperform
Lakefront Biotherapeutics American Depositary Shares stock logo
LKFT
Lakefront Biotherapeutics American Depositary Shares
11/7/2025Boost Price Target$31.38$32.00Sector Perform
Cidara Therapeutics, Inc. stock logo
CDTX
Cidara Therapeutics
11/7/2025Boost Price Target$99.95$145.00Outperform
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
11/6/2025Lower Price Target$21.35$32.00Outperform
PTC Therapeutics, Inc. stock logo
PTCT
PTC Therapeutics
11/5/2025Boost Price Target$72.90$82.00Outperform
Xenon Pharmaceuticals Inc. stock logo
XENE
Xenon Pharmaceuticals
11/4/2025Boost Price Target$39.54$58.00Outperform
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
11/4/2025Lower Price Target$430.41$415.00Sector Perform
Karyopharm Therapeutics Inc. stock logo
KPTI
Karyopharm Therapeutics
11/4/2025Lower Price Target$5.66$19.00Outperform
Apogee Therapeutics Inc. stock logo
APGE
Apogee Therapeutics
11/3/2025Boost Price Target$57.13$70.00Outperform
Biogen Inc. stock logo
BIIB
Biogen
10/31/2025Lower Price Target$149.61$210.00Outperform
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
10/31/2025Boost Price Target$120.73$105.00Sector Perform
Incyte Corporation stock logo
INCY
Incyte
10/29/2025Boost Price Target$89.19$84.00Sector Perform
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
10/29/2025Boost Price Target$654.96$708.00Sector Perform
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
10/29/2025Boost Price Target$139.82$160.00Outperform
Lakefront Biotherapeutics American Depositary Shares stock logo
LKFT
Lakefront Biotherapeutics American Depositary Shares
10/22/2025Boost Price Target$32.33$28.00Sector Perform
Biogen Inc. stock logo
BIIB
Biogen
10/8/2025Lower Price Target$152.21$217.00Outperform
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
10/8/2025Boost Price Target$116.78$100.00Sector Perform
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
10/8/2025Boost Price Target$24.02$16.00Sector Perform
MoonLake Immunotherapeutics stock logo
MLTX
MoonLake Immunotherapeutics
9/29/2025Reiterated Rating$6.86$10.00Sector Perform
Apogee Therapeutics Inc. stock logo
APGE
Apogee Therapeutics
9/25/2025Initiated Coverage$38.42$60.00Outperform
Cidara Therapeutics, Inc. stock logo
CDTX
Cidara Therapeutics
9/24/2025Set Price Target$88.16$137.00Outperform
Incyte Corporation stock logo
INCY
Incyte
9/24/2025Boost Price Target$84.54$81.00Sector Perform
Kymera Therapeutics, Inc. stock logo
KYMR
Kymera Therapeutics
9/16/2025Initiated Coverage$47.28$70.00Outperform
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
9/5/2025Boost Price Target$143.76$149.00Outperform
Sionna Therapeutics, Inc. stock logo
SION
Sionna Therapeutics
9/3/2025Initiated Coverage$25.39$22.00Sector Perform
Xenon Pharmaceuticals Inc. stock logo
XENE
Xenon Pharmaceuticals
9/2/2025Reiterated Rating$39.12$55.00Outperform
Aardvark Therapeutics, Inc. stock logo
AARD
Aardvark Therapeutics
8/14/2025Lower Price Target$11.44$19.00Outperform
Xenon Pharmaceuticals Inc. stock logo
XENE
Xenon Pharmaceuticals
8/12/2025Lower Price Target$36.96$55.00Outperform
PTC Therapeutics, Inc. stock logo
PTCT
PTC Therapeutics
8/8/2025Reiterated Rating$46.87$63.00Outperform
89BIO stock logo
ETNB
89BIO
8/8/2025Lower Price Target$8.92$11.00Sector Perform
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
8/8/2025Boost Price Target$119.21$98.00Sector Perform
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
8/7/2025Boost Price Target$23.84$40.00Outperform
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
8/5/2025Lower Price Target$389.93$405.00Sector Perform
Prothena Corporation plc stock logo
PRTA
Prothena
8/5/2025Lower Price Target$7.28$10.00Sector Perform
Trump’s Plan To Cheat History (Ad)

China has slashed its U.S. Treasury holdings by more than 45% from their peak, while building gold vaults and payment networks that bypass the dollar entirely. Since the Federal Reserve opened in 1913, the dollar has lost most of its purchasing power. Porter Stansberry argues a new monetary order is forming around AI infrastructure, chips and energy, pointing to stocks like Vertiv, GE Vernova and Arista Networks that have surged hundreds of percent in recent years.tc pixel

Watch Porter Stansberry's full interview and see his top pick now
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
8/4/2025Boost Price Target$569.71$695.00Sector Perform
Biogen Inc. stock logo
BIIB
Biogen
8/1/2025Boost Price Target$126.28$219.00Outperform
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
7/31/2025Lower Price Target$129.41$144.00Outperform
Incyte Corporation stock logo
INCY
Incyte
7/30/2025Boost Price Target$77.88$72.00Sector Perform
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
7/17/2025Lower Price Target$21.46$23.00Sector Perform
BioCryst Pharmaceuticals, Inc. stock logo
BCRX
BioCryst Pharmaceuticals
6/30/2025Reiterated Rating$9.23$13.00Outperform
Biogen Inc. stock logo
BIIB
Biogen
6/25/2025Set Price Target$126.16$213.00Outperform
Cidara Therapeutics, Inc. stock logo
CDTX
Cidara Therapeutics
6/24/2025Upgrade$49.86$75.00Moderate Buy
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
6/23/2025Boost Price Target$22.12$38.00Outperform
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
6/17/2025Lower Price Target$448.47$420.00Sector Perform
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
5/27/2025Reiterated Rating$599.20$662.00Sector Perform
Contineum Therapeutics, Inc. stock logo
CTNM
Contineum Therapeutics
5/15/2025Reiterated Rating$3.72$31.00Outperform
Karyopharm Therapeutics Inc. stock logo
KPTI
Karyopharm Therapeutics
5/13/2025Lower Price Target$5.40$33.00Outperform
Xenon Pharmaceuticals Inc. stock logo
XENE
Xenon Pharmaceuticals
5/13/2025Lower Price Target$29.93$55.00Outperform
Corbus Pharmaceuticals Holdings, Inc. stock logo
CRBP
Corbus Pharmaceuticals
5/7/2025Lower Price Target$6.34$58.00Outperform
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
5/6/2025Boost Price Target$434.64$423.00Sector Perform
BioCryst Pharmaceuticals, Inc. stock logo
BCRX
BioCryst Pharmaceuticals
5/6/2025Reiterated Rating$10.40$13.00Outperform
Biogen Inc. stock logo
BIIB
Biogen
5/2/2025Lower Price Target$122.38$205.00Outperform
Incyte Corporation stock logo
INCY
Incyte
4/30/2025Boost Price Target$61.11$67.00Sector Perform
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
4/30/2025Lower Price Target$586.51$943.00Outperform
Legend Biotech Corporation Sponsored ADR stock logo
LEGN
Legend Biotech
4/22/2025Reiterated Rating$33.48$84.00Outperform
Biogen Inc. stock logo
BIIB
Biogen
4/22/2025Boost Price Target$117.63$225.00Outperform
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
4/14/2025Upgrade$90.87$137.00Outperform
BioCryst Pharmaceuticals, Inc. stock logo
BCRX
BioCryst Pharmaceuticals
4/11/2025Reiterated Rating$6.55$11.00Outperform
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
4/1/2025Boost Price Target$487.06$420.00Sector Perform
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
3/31/2025Downgrade$70.41$87.00Sector Perform
MoonLake Immunotherapeutics stock logo
MLTX
MoonLake Immunotherapeutics
3/18/2025Initiated Coverage$38.67$67.00Outperform
Aardvark Therapeutics, Inc. stock logo
AARD
Aardvark Therapeutics
3/10/2025Initiated Coverage$10.13$21.00Outperform
GH Research PLC stock logo
GHRS
GH Research
3/7/2025Initiated Coverage$10.55$31.00Outperform
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
2/27/2025Lower Price Target$107.24$161.00Outperform
BioCryst Pharmaceuticals, Inc. stock logo
BCRX
BioCryst Pharmaceuticals
2/25/2025Reiterated Rating$8.11$11.00Outperform
Prothena Corporation plc stock logo
PRTA
Prothena
2/21/2025Lower Price Target$15.61$20.00Sector Perform
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
2/20/2025Boost Price Target$475.68$408.00Sector Perform
Karyopharm Therapeutics Inc. stock logo
KPTI
Karyopharm Therapeutics
2/20/2025Reiterated Rating$9.41$45.00Outperform
Biogen Inc. stock logo
BIIB
Biogen
2/13/2025Lower Price Target$135.56$225.00Outperform
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
2/12/2025Boost Price Target$103.52$90.00Sector Perform
Incyte Corporation stock logo
INCY
Incyte
2/11/2025Lower Price Target$68.30$68.00Sector Perform
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
2/11/2025Boost Price Target$459.15$407.00Sector Perform
Pliant Therapeutics, Inc. stock logo
PLRX
Pliant Therapeutics
2/10/2025Downgrade$7.79$4.00Sector Perform
Karyopharm Therapeutics Inc. stock logo
KPTI
Karyopharm Therapeutics
2/10/2025Reiterated Rating$9.77$45.00Outperform
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
2/7/2025Lower Price Target$122.00$148.00Sector Perform
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
2/3/2025Reiterated Rating$99.12$84.00Sector Perform
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
1/29/2025Reiterated Rating$104.53$139.00Outperform